New NIH grant awards $2.5 million over 5 years for mechanistic studyBURLINGTON, Mass. and JERUSALEM, Nov. 04, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded a new grant – totaling approximately $2.5 million over five years – to a research team led by Principal Investigator Dr. Claudia Padu ...

MIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Captivision Inc. (“Captivision” or the “Company”) (NASDAQ: CAPT), a pioneering manufacturer and global LED solution provider, announced that it has been informed that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request to extend the deadline for regaining compliance with the Listing Rules of The Nasdaq Stock Market (“Nasdaq”), subject to certain conditions related to the Company’s ongoing efforts to regain compliance with Nasdaq Listing Rule 525 ...

WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that President and CEO, Mike Raab will participate in a fireside chat at the Wedbush Rewind ASN 2025 Conference on Monday, November 10, 2025 from 11:30 a.m. to 12:00 p.m. ET. To access the public webcast of the event, please visit the Events and ...

公司近期活动 - 公司将参加Guggenheim第二届年度医疗健康创新大会，并进行炉边谈话，时间为2025年11月11日下午1:30 [1][4] - 公司将参加Stifel 2025医疗健康大会，并进行演讲，时间为2025年11月12日下午2:00 [1][4] - 相关活动的网络直播回放将在公司网站上存档90天 [1] 公司业务与研发管线 - 公司是一家后期生物制药公司，致力于为免疫介导性疾病患者开发新一代靶向疗法 [2] - 公司利用其专有数据分析平台和精准医疗方法，正在开发一系列口服酪氨酸激酶2抑制剂管线 [2] - 主要候选药物envudeucitinib用于治疗中重度斑块状银屑病和系统性红斑狼疮等系统性免疫介导疾病 [2] - 候选药物A-005用于治疗神经炎症和神经退行性疾病 [2] - 管线还包括lonigutamab，一种用于治疗甲状腺眼病的皮下注射抗胰岛素样生长因子1受体疗法 [2] - 公司还拥有多个通过其精准方法识别的临床前项目 [2]

Three iadademstat abstracts have been accepted for presentation at the upcoming ASH-2025 Annual MeetingPreliminary data from the ongoing Phase Ib trial combining iadademstat with azacitidine and venetoclax in newly diagnosed, unfit AML patients showed a 100% overall response rateUpdated preliminary data from the ongoing Phase Ib FRIDA trial evaluating iadademstat in combination with gilteritinib in FLT3-mutated relapsed/refractory AML showed a 67% response rate in the expanded dose, superior to both histori ...

LA JOLLA, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Private Bancorp of America, Inc. (OTCQX:PBAM), (“Company”) and CalPrivate Bank (“Bank”) are proud to announce the grand opening of CalPrivate Bank’s newest regional branch offices in Montecito serving California’s Central Coast. This new location expands the Bank’s commitment to delivering our trademark Distinctively Different® personalized banking services and strengthening community relationships across the region. The full-service office, located at 148 ...

GREENWICH, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQH) (the “Company,” “we,” “us” or “our”) announced today its financial results and related information for the quarter ended September 30, 2025. On October 30, 2025, our Board of Directors declared the following distributions on our common stock: Month EndingRecord DatePayment DateAmount Per ShareJanuary 31, 2026January 16, 2026January 30, 2026$0.035February 28, 2026February 13, 2 ...

SAN DIEGO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of systemically delivered, targeted genetic medicines, today announced that it will hold an investor event at the Society of Immunotherapy for Cancer (SITC) Annual Meeting centered around the Company’s groundbreaking RedTail platform and its lead candidate, CLD-401. The presentation will take place at the SITC Annual Me ...

FREMONT, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that its IQ® Battery systems are now eligible for San Diego Community Power’s (Community Power) Solar Battery Savings program. Community Power is a leading California community choice aggregator serving nearly one million customers across the greater San Diego region. The Solar Battery Sav ...

OAK BROOK, Ill., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Portillo’s Inc. (“Portillo’s” or the “Company”) (NASDAQ: PTLO), the one-of-a-kind restaurant concept known for its menu of Chicago-style favorites, today reported financial results for the third quarter ended September 28, 2025. Third Quarter 2025 Performance Highlights (vs. Third Quarter 2024): Total revenue of $181.4 million, an increase of 1.8% or $3.2 millionSame-restaurant sales decrease of -0.8%Operating income of $5.4 million, a decrease of $10.6 mil ...